Back to Stakeholders
Research, Drug Development & ManufacturingLead program: Pre-clinical
Alvarius Pharmaceuticals
1 Drug Candidate
Alvarius Pharmaceuticals is an Irish bio-pharmaceutical company developing 5-MeO-DMT-based therapies for addiction and substance use disorders. Founded in 2021 and based in Dublin, the company conducts preclinical studies in collaboration with University College Dublin, combining acute 5-MeO-DMT administration with guided psychotherapy. Alvarius raised €5.5M in 2023 and has filed one patent.
Drug Pipeline
15-MeO-DMT
5-MeO-DMTPre-clinical
Preclinical studies with UCD investigating 5-MeO-DMT-assisted psychotherapy for addiction and substance use disorders.
Quick Facts
- Type
- Private Biotech
- Founded
- 2021
- Lead Stage
- Pre-clinical
- Website
- Visit